Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Suntex unit JA Development signs construction management deal with Airtopia Group

Suntex unit JA Development signs construction management deal with Airtopia Group

ReutersReuters2026/08/07 14:07
  • Suntex Enterprises’ wholly owned JA Development & Construction signed a definitive construction management agreement with Airtopia Group.
  • JA Development becomes Airtopia’s construction management and general contracting partner, with projects authorized through separate work orders.
  • Initial development package targets Roswell, New Mexico and Bedford, Texas; Roswell expected to advance first once a work order is executed.
  • Plan contemplates 8 to 14 additional Airtopia locations over 18 months, with an estimated program value of USD 60 million to USD 84 million.
  • Suntex may deploy Deep South Electrical Contractors or GoldenEra Development on a project-by-project basis to support delivery.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Suntex Enterprises Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608071005ACCESSWRNAPR_____1204557) on August 07, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.